OraSure Technologies (NASDAQ:OSUR) Stock Price Breaks Above 200-Day Moving Average – Should You Sell?

OraSure Technologies, Inc. (NASDAQ:OSUR)’s share price passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $3.64 and traded as high as $4.02. OraSure Technologies shares last traded at $3.95, with a volume of 848,227 shares traded.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of OraSure Technologies in a research note on Tuesday, September 1st. Wall Street Zen upgraded OraSure Technologies from a “sell” rating to a “hold” rating in a research note on Monday, August 10th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and an average price target of $3.00.

OraSure Technologies Trading Up 2.0%

The stock’s 50 day moving average price is $3.77 and its two-hundred day moving average price is $3.65. The firm has a market capitalization of $268.63 million, a price-to-earnings ratio of -5.64 and a beta of 0.99.

Institutional Trading of OraSure Technologies

Several institutional investors have recently modified their holdings of the company. Headlands Technologies LLC bought a new position in shares of OraSure Technologies in the second quarter valued at $67,000. Susquehanna International Group LLP raised its position in shares of OraSure Technologies by 29.4% during the second quarter. Susquehanna International Group LLP now owns 198,779 shares of the medical instruments supplier’s stock worth $887,000 after acquiring an additional 45,169 shares during the last quarter. Two Sigma Securities LLC acquired a new position in shares of OraSure Technologies in the 2nd quarter worth approximately $55,000. Cannell Capital LLC bought a new stake in OraSure Technologies during the second quarter valued at $6,366,289. Finally, Public Employees Retirement System of Ohio acquired a new position in shares of OraSure Technologies in the 2nd quarter valued at about $416,000. Institutional investors and hedge funds own 93.50% of the company’s stock.

About OraSure Technologies

OraSure Technologies, Inc is a diagnostics and specimen-collection company that develops, manufactures and distributes point-of-care and at-home testing products, collection devices and laboratory technologies. Its solutions are used in infectious-disease screening, molecular testing, genomics, microbiome research and other applications requiring the collection, stabilization and analysis of biological samples.

The company is best known for its OraQuick portfolio of rapid tests, including oral-fluid tests for HIV and hepatitis C.